Epiomic Epidemiology Series Reports

In an effort to provide a more condensed version of our Epiomic Patient segmentation database for our clients, we have developed a new range of reports called the Epiomic Epidemiology Series. Each of these publications will be disease specific and will typically cover between 8-10 Major Global Markets with a forecasted horizon of 10 years. Each report will begin with some analyst insights about the disease or disorder which will look specifically at the patient population and provide some insight related to:
  • the cause of the disease
  • risk factors and prevention
  • the diagnosis
  • variations by geography or ethnicity,
  • key co morbid conditions associated with the disease
  • disease prognosis and clinical course
The majority of the report will be presented in easy to understand data tables showing the patients prevalence by the specific country across a 10 year horizon period. Each report will have the overall top-line prevalence for the disease in each country along with a split by gender. To add a further level of detail, we have provided a breakdown of the prevalence or incidence population by gender in 5 year cohorts for each country in the report.   A real benefit of using the Epiomic patient segmentation database as a source is its ability to look beyond just the prevalence and incidence rate of a disease, and show relevant sub-populations. These sub-populations could be either a key co-morbid condition or some other attributes that are important to understand when considering the current and future treatment or diagnostic pathway for a specific disease. All of these sub-populations have been displayed in a table format with each population segmented even further by country or other parameters related to the sub-population.   These reports are built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Thyroid Cancer Forecast in 21 Major Markets 2018-2028

January 2018 | Cancer |

Thyroid cancer is a cancer originating from follicular or parafollicular thyroid cells. It is a relatively rare cancer, but the most common of the endocrine system. The main clinical split is between differentiated and undifferentiated tumour types, with the majority being well-differentiated. This report provides the current incident population for…

  • AR, AU, BR, CA, CN, FR, DE, IN, IT, JP, MX, NL, PL, RU, SA, ZA, KR, ES, TR, UK, US

Type 2 Diabetes Mellitus Forecast in 22 Major Markets 2018-2028

Type 2 diabetes mellitus (T2DM) is a cluster of diseases characterised by high levels of blood glucose, as well as inability of the body to produce sufficient insulin coupled with systemic desensitisation to insulin. Although not exclusively, T2DM is associated with lifestyle factors including unhealthy diet, physical inactivity and obesity….

  • AR, AU, BR, CA, CN, DK, FR, DE, IN, IT, JP, MX, NL, NO, PL, RU, KR, ES, SE, TR, UK, US
Purchase

Parkinson’s Disease Forecast in 19 Major Markets 2018-2028

Parkinson’s disease (PD) is a neurodegenerative disorder that seriously affects everyday activities. PD is an age-related, progressive disease characterised by the damage to and death of dopaminergic neurons in the substantia nigra, as well as other regions of the brain. This results in the onset and development of various motor…

  • AR, AU, BR, CA, CN, FR, DE, IN, IT, JP, MX, NL, PL, RU, KR, ES, TR, UK, US
Purchase

Lower Urinary Tract Symptoms Forecast in 12 Major Markets 2018-2028

Lower urinary tract symptoms (LUTS) are a standardised group of symptoms related to problems with the voiding, storage and post-micturition of urine, occurring in both males and females. Differences between sexes regarding the type and frequency of symptoms have been observed. LUTS are a major burden for middle-aged and elderly…

  • BR, CA, CN, FR, DE, IN, IT, JP, RU, ES, UK, US
Purchase

Chronic Heart Failure Forecast in 12 Major Markets 2018-2028

January 2018 | Heart & Cardiovascular |

Chronic heart failure (CHF) is a chronic disease during which the heart is not able to supply sufficient blood flow to the body. Exacerbations of CHF are characterised by dyspnoea at rest or on exertion and worsening fluid retention, apparent as lung congestion and/or swollen ankles and legs. The disease…

  • BR, CA, CN, FR, DE, IN, IT, JP, RU, ES, UK, US
Purchase

Niemann–Pick Type C Disease Forecast in 11 Major Markets 2017-2027

Niemann–Pick type C (NP-C) disease is a rare autosomal recessive lysosomal storage disorder with a variety of neurovisceral manifestations. It is caused by mutations in either NPC1 (more common) or NPC2 (less common) genes that lead to accumulation of cholesterol and glycosphingolipids in tissues. NP-C is divided according to the…

  • BR, CA, CN, FR, DE, IT, JP, ES, UK, US
Purchase